Previous 10 | Next 10 |
Gainers: Organogenesis (NASDAQ:ORGO) +24%. CytomX Therapeutics (NASDAQ:CTMX) +13%. X4 Pharmaceuticals (NASDAQ:XFOR) +13%. MannKind (NASDAQ:MNKD) +10%. Allied Healthcare (NASDAQ:AHPI) +6%. Losers: Karyopharm Therapeutics (NASDAQ:KPTI) -31%. Bright Health Grou...
The shares of the commercial-stage pharmaceutical company, Karyopharm Therapeutics (NASDAQ:KPTI) have lost ~28% in the pre-market Wednesday amid concerns that the company will need another trial to support its request for U.S. label expansion of cancer therapy, Xpovio (selinexor). F...
Gainers: SoFi Technologies SOFI +20%. Scientific Games Corp SGMS +10%. CytomX Therapeutics CTMX +10%. ZimVie (ZIMV) +9%. PLBY Group PLBY +9%. Losers: Karyopharm Therapeutics (NASDAQ:KPTI) -27%. HOOKIPA Pharma HOOK -20%. Proterra PTRA -...
Karyopharm Provides U.S. Regulatory Update on Selinexor in Advanced or Recurrent Endometrial Cancer Following Discussion with the FDA, Karyopharm Plans to Initiate a New Placebo-Controlled Randomized Study of Selinexor in the Advanced or Recurrent Endometrial Cancer p53 Wild-Typ...
Shares of Karyopharm Therapeutics (NASDAQ: KPTI) , a biopharmaceutical company developing new cancer drugs, are tanking Tuesday as investors respond to an unexpected leadership change. The stock was trading 30.5% lower as of 11:52 a.m. ET. On Feb. 8, shares of Karyopharm s...
Gainers: Indonesia (NYSE:INDO) +79%. Meritor (NYSE:MTOR) +45%. Ocugen (NASDAQ:OCGN) +22%. Datasea (NASDAQ:DTSS) +20%. IronNet (NYSE:IRNT) +20%. Riley Exploration Permian (NYSE:REPX) +19%. Arteris (NASDAQ:AIP) +17%. Houghton Mifflin Harcourt Company (NASDAQ:HMHC) +15%. MEDIROM Healthcare Techn...
Gainers: HOOKIPA Pharma HOOK +18%. Nuvectis Pharma (NASDAQ:NVCT) +16%. Ocugen OCGN +14%. Privia Health (NASDAQ:PRVA) +12%. IMARA (NASDAQ:IMRA) +11%. Losers: Allarity Therapeutics (NASDAQ:ALLR) -29%. Homology Medicines FIXX -27%. Karyopharm The...
Homology Medicines (NASDAQ:FIXX) -25% on FDA clinical hold for phenylketonuria trial. Karyopharm Therapeutics (NASDAQ:KPTI) -23% as medical chief steps down. Inspirato (NASDAQ:ISPO) -17%. QIWI (NASDAQ:QIWI) -14%. Yandex (NASDAQ:YNDX) -13%. Energy Vault (NYSE:NRGV) -12%. Ar...
Karyopharm Therapeutics (NASDAQ:KPTI) has lost ~24% in the pre-market Tuesday after the company announced that its Executive Vice President and Chief Medical Officer Jatin Shah had decided to step down to pursue other opportunities. However, Dr. Shah will continue to serve the compa...
Karyopharm Announces Changes to Its Clinical Leadership Team − Patricia Judson, M.D., Formerly of GSK and AstraZeneca, Appointed as Senior Vice President of Medical Strategy - − Stuart Poulton, Formerly of AbbVie, Amgen, and Eli Lilly, Joins as Senior Vice Pres...
News, Short Squeeze, Breakout and More Instantly...
Karyopharm Therapeutics Inc. Company Name:
KPTI Stock Symbol:
NASDAQ Market:
Karyopharm Therapeutics Inc. Website:
Karyopharm to Report Second Quarter 2024 Financial Results on August 6, 2024 PR Newswire -- Conference Call Scheduled for Tuesday, August 6, 2024 , at 8:00 a.m. ET -- NEWTON, Mass. , July 31, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasd...
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates PR Newswire Long-Term Follow-Up Data Signal Promising Progression-Free S...
Karyopharm to Participate at the Jefferies Global Healthcare Conference PR Newswire NEWTON, Mass. , May 29, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announ...